Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1213-1217

  Zhang, Ming ^a,b   Gong, Jianhua ^a,b   Yang, Zhenhua ^a,b   Samten, Buka ^a,b   Cave, M Donald ^a,b   Barnes, Peter F ^a,b,c  

^a Ctr Pulmon and Infect Dis Contr   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NITROGEN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; GROWTH RATE; HUMAN; HUMAN CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

CELLS, CULTURED; COLONY COUNT, MICROBIAL; HUMANS; INTERLEUKINS; MACROPHAGES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; NITRITES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0033046430     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314738     Document Type: Article

References (24)

1. 1. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-6.
2. 2. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.
3. 3. Burman WJ, Reves RR, Hawkes AP, et al. DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997;155:1140-6.
4. 4. Barnes PF, Yang Z, Preston-Martin S, et al. Patterns of tuberculosis transmission in central Los Angeles. JAMA 1997;278:1159-63.
5. 5. Valway SE, Sanchez MPC, Shinnick TM, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998;338:633-9.
6. 6. Zhang M, Gong J, Lin Y, Barnes P. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 1998;66:794-9.
7. 7. Friedman CR, Quinn GC, Kreiswirth BN, et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis 1997;176:478-84.
8. 8. Yang Z, Barnes PF, Chaves F, et al. Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol 1998;36:1003-7.
9. 9. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
10. 10. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SHE. Lethal tuberculosis in interleukin-6 deficient mutant mice. Infect Immun 1997;65:4843-9.
11. 11. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997;186:39-45.
12. 12. Wakeham J, Wang J, Magram J, et al. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis Bacillus Calmette-Guerin in IL-12 deficient mice. J Immunol 1998;160:6101 -11.
13. 13. Hirsch CS, Ellner JJ, Russell DG, Rich EA. Complement receptor mediated uptake and tumor necrosis factor-α mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994;152:743-53.
14. 14. Frucht DM, Holland SM. Defective monocyte costimulation for IFNγ production in familial disseminated Mycobacterium avium complex infection. Abnormal IL-12 regulation. J Immunol 1996;157:411-6.
15. 15. De Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in inter]eukin-I2 receptor deficient patients. Science 1998;280: 1435-8.
16. 16. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280: 1432-5.
17. 17. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-21.
18. 18. Gong JH, Zhang M, Modlin RL, et al. Inlerleukin-10 downregulates Mycobacterium tuberculosis induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64:913-8.
19. 19. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
20. 20. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997;94:5243-8.
21. 21. Nicholson S, Bonecini-Almeida MG, Lapa e Silva JR. et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-302.
22. 22. Rich EA, Torres M, Sada F, Finegan CK, Hamilton BD, Toossi Z. Mycobacterium tuberculosis (MTB) stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuberc Lung Dis 1997;78:247-55.
23. 23. Molloy A, Laochumroonvorapong P, Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular Bacillus Calmette-Guerin. J Exp Med 1994;180:1499-509.
24. 24. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. Fas ligand induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998;160: 5448-54.